$CRSP CRISPR Therapeutics AG Insider Trading Week 10/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG in week 10/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 133.88 | 25,360 | 3,395,197 | 25,360 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Payment of Exercise | F | 124.15 | 1,352 | 167,851 | 1,891 | 3.2 K to 1.9 K (-41.69 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,833 | 0 | 3,243 | 410 to 3.2 K (+690.98 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | A | 0.00 | 36,000 | 0 | 36,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | A | 133.88 | 100,000 | 13,388,000 | 100,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Payment of Exercise | F | 124.15 | 5,526 | 686,053 | 188,498 | 194 K to 188.5 K (-2.85 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 0.00 | 11,833 | 0 | 194,024 | 182.2 K to 194 K (+6.49 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Option Exercise | A | 133.88 | 33,334 | 4,462,756 | 33,334 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Payment of Exercise | F | 124.15 | 2,141 | 265,805 | 13,050 | 15.2 K to 13.1 K (-14.09 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Klein Lawrence Otto | CBO & COO | Buy | M | 0.00 | 4,583 | 0 | 15,191 | 10.6 K to 15.2 K (+43.20 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 133.88 | 25,360 | 3,395,197 | 25,360 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Payment of Exercise | F | 124.15 | 1,353 | 167,975 | 23,911 | 25.3 K to 23.9 K (-5.36 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Buy | M | 0.00 | 2,833 | 0 | 25,264 | 22.4 K to 25.3 K (+12.63 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Option Exercise | A | 133.88 | 23,334 | 3,123,956 | 23,334 | |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Payment of Exercise | F | 124.15 | 2,141 | 265,805 | 38,304 | 40.4 K to 38.3 K (-5.29 %) |
| Mar 12 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Buy | M | 0.00 | 4,583 | 0 | 40,445 | 35.9 K to 40.4 K (+12.78 %) |
| Mar 09 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Payment of Exercise | F | 114.65 | 1,585 | 181,720 | 35,862 | 37.4 K to 35.9 K (-4.23 %) |
| Mar 09 2021 | CRSP | CRISPR Therapeutic ... | Ho Tony W | Executive VP, Head ... | Buy | M | 0.00 | 3,333 | 0 | 37,447 | 34.1 K to 37.4 K (+9.77 %) |